April 4 2025 The preclinical study of biocompatibility of tyrosine polycarbonate bioresorbable scaffold in small caliber porcine peripheral arteries Sabine Konhaeuser Press Releases
April 3 2024 Long-term safety and effectiveness of the Fantom bioresorbable coronary artery scaffold: final results of the FANTOM II trial Sabine Konhaeuser Press Releases
September 27 2022 REVA MEDICAL ANNOUNCES INITIATION OF ENROLLMENT IN THE MOTIV IDE CLINCIAL TRIAL Tim Ho Press Releases
May 24 2022 REVA MEDICAL ANNOUNCES FINAL 5 YEAR RESULTS FOR IT’S FANTOM II CORONARY SCAFFOLD STUDY Tim Ho Press Releases
November 8 2021 Shaping the future of vascular stenting – REVA Medical and B. Braun form new Partnership Tim Ho Press Releases